Abstract
The purpose of this study was to explore the relationship between the preoperative plasma D-dimer (DD) levels and the tumor pathology of colorectal cancer. The plasma DD levels were measured preoperatively in 108 patients with colorectal cancer, and then were correlated with the tumor pathology and stage. The diagnostic value of the DD levels for the tumor stage was then compared with that of the preoperative carcinoembryonic antigen (CEA) levels. The preoperative DD levels were higher in patients with either a large-sized tumor or a tumor showing deep wall penetration. Lymph-node metastasis, lymphatic invasion, hepatic metastasis, and peritoneal dissemination were all associated with higher DD levels. A stepwise increase in the median DD level was found with the tumor stage. The preoperative DD levels also significantly correlated with CEA levels. When a cutoff value of 0.6μ/ml was used in the DD assay, the sensitivity and specificity for Dukes C or D cancer were 67.2% and 64.0%, and those for Dukes D cancer were 91.3% and 57.6%, respectively. Although the DD assay was less specific, its diagnostic value in the preoperative staging of colorectal cancer was comparable to that of the CEA assay. The measurement of the preoperative DD level is thus considered to be useful for the preoperative staging of colorectal cancer.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Rickles FR, Edwards RL (1983) Activation of blood coagulation in cancer: Trousseau’s syndrome revisited. Blood 62:14–31
Glassman AB, Jones E (1994) Thrombosis and coagulation abnormalities associated with cancer. Ann Clin Lab Sci 24:1–5
Bick RL, Baker WF (1992) Diagnostic efficacy of the D-dimer assay in disseminated intravascular coagulation (DIC). Thromb Res 65:785–790
Rella C, Coviello M, Trenza ND, Falco G, Chiuri E, Colavito P, Quaranta M, Lenardis AD (1993) Plasma D-dimer measurement as a marker of gynecologic tumors: comparison with CA 125. Tumori 79:347–351
Gadducci A, Baicchi U, Marrai R, Ferdeghini M, Bianchi R, Facchini V (1996) Preoperative evaluation of D-dimer and CA 125 levels in differentiating benign from malignant ovarian masses. Gynecol Oncol 60:197–202
Gadducci A, Baicchi U, Marrai R, Facchini V, Bravo BD, Fosella PV, Fioretti P (1993) Pretreatment plasma levels of fibrinopeptide-A (FPA), D-dimer (DD), and von Willebrand factor (vWF) in patients with operable cervical cancer: influence of surgical-pathological stage, tumor size, histologic type, and lymph node status. Gynecol Oncol 49:354–358
Gabazza EC, Taguchi O, Yamakami T, Machishi M, Ibata H, Suzuki S (1993) Evaluating prethrombotic state in lung cancer using molecular markers. Chest 103:196–200
Gabazza EC, Taguchi O, Yamakami T, Machishi M, Ibata H, Suzuki S (1993) Correlation between increased granulocyte elastase release and activation of blood coagulation in patients with lung cancer. Cancer 72:2134–2140
Nakashima J, Tachibana M, Ueno M, Baba S, Tazaki H (1995) Tumor necrosis factor and coagulopathy in patients with prostatic cancer. Cancer Res 55:4881–4885
Edwards CM, Warren J, Armstrong L, Donnely PK (1993) Ddimer: a useful marker of disease stage in surgery for colorectal cancer. Br J Surg 80:1404–1405
Wojtukiewicz MZ, Zacharski LR, Memolo VA, Kisiel W, Kudryk BJ, Rousseau SM, Stump DC (1989) Indirect activation of blood coagulation in colon cancer. Thromb Haemostas 62:1062–1066
Pineo GF, Regoeczi E, Hatton NW, Brain MC (1973) The activation of coagulation by extracts of mucus: a possible pathway of intravascular coagulation accompanying adenocarcinomas. J Lab Clin Med 82:255–266
Dover R, Goeting NJM, Taylor I, Roath OS, Francis JL (1987) Factor X-activating activity in patients with colorectal carcinoma. Br J Surg 74:1122–1124
Tissot J-D, Hauert J, Bachmann F (1984) Characterization of plasminogen activators from normal human breast and colon and from breast and colon carcinomas. Int J Cancer 34:295–302
Burtin P, Chavanel G, Andre-Bougaran J, Gentile A (1987) The plasmin system in human adenocarcinomas and their metastases. A comparative immunofluorescence study. Int J Cancer 39:170–178
Kohga S, Harvey SR, Weaver RM, Markus G (1985) Localization of plasminogen activator in human colon cancer by immunoperoxidase staining. Cancer Res 45:1787–1796
Markus G, Camiolo SM, Kohga S, Madeja JM, Mittelman A (1983) Plasminogen activator secretion of human tumors in shortterm organ culture, including a comparison of primary and metastatic colon tumors. Cancer Res 43:5517–5525
Kirchheimer JC, Huber K, Wagner O, Binder BR (1987) Patterns of fibrinolytic parameters in patients with gastrointestinal carcinomas. Br J Haematol 66:85–89
Reich R, Thompson EW, Iwamoto Y, Martin GR, Deason JR, Fuller GC, Miskin R (1988) Effects of inhibitors of plasminogen activator, serine proteinases, and collagenase IV on the invasion of basement membrane by metastatic cells. Cancer Res 48:3307–3312
Wanebo HJ, Rao B, Pinsky CM, Hoffman RG, Stearns M, Schwartz MK, Oetthen HF (1978) Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer. N Engl J Med 299:448–451
Goslin R, Steele G, Macintyre J, Mayer T, Sugarbaker P, Cleghorn K, Wilson R, Zamcheck N (1980) The use of preoperative plasma CEA levels for the stratification of patients after curative resection of colorectal cancers. Ann Surg 192:747–751
Moertel CG, O’Fallon JR, Go VLW, O’Connel MJ, Thynne GS (1986) The preoperative carcinoembryonic antigen test in the diagnosis, staging, and prognosis of colorectal cancer. Cancer 58:603–610
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Oya, M., Akiyama, Y., Yanagida, T. et al. Plasma D-dimer level in patients with colorectal cancer: Its role as a tumor marker. Surg Today 28, 373–378 (1998). https://doi.org/10.1007/s005950050144
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s005950050144